WHO Collects Tuberculosis Data In European Region

Ruzanna Harutyunyan's picture
Advertisement

The European Centre for Disease Prevention and Control (ECDC) and WHO/Europe have agreed jointly to continue the surveillance of TB in the WHO European Region, sharing data collection, validation and analysis and the dissemination of information and other tasks.

ECDC and WHO/Europe announce the start of collection of data for surveillance and on management of TB control programmes in 2007. The reporting period starts on 1 July 2008 and ends 30 September 2008.

To maintain data completeness and geographical coverage, a user-friendly solution has been developed: the ECDC–WHO/Europe joint TB information system. It includes three key elements:

1. common entry point/web site;

2. The European Surveillance System (TESSy); and

3. the centralized information system for infectious diseases (CISID).

All Member States in the WHO European Region may upload information to the ECDC–WHO/Europe joint TB information system via a common interface.

National correspondents uploading data will be automatically redirected to the appropriate elements of the system, according to:

Advertisement

1. reported disease;

2. country affiliation to the European Union (EU) and the European Economic Area (EEA)/European Free Trade Association (EFTA); and

3. the type of information to be uploaded.

Because a wide spectrum of information is requested, requiring the national TB correspondents to collect data from the respective organization(s) involved in the national TB programme, they can complete the form in several steps.

Countries outside the EU/EEA/EFTA can submit the requested information offline. National TB correspondents are welcome to download a data collection form in a Microsoft Excel format, and then submit it to the CISID contact point.

As in previous years, the data collection questionnaire on drug resistance surveillance (DRS) includes sections on:

* laboratory network and quality control;

* characteristics of drug resistance surveillance;

* results of drug-susceptibility testing at the start of treatment.

National TB correspondents should download the DRS forms, fill them in on their own computers and submit them by e-mail to TESSy or CISID, according to the country’s affiliation to EU and EEA/EFTA. Correspondents who have any problems preparing the data are welcome to contact the system help desks.

Advertisement